Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model

Gastric Emptying Clinical Trial

Official title:

Exploring the Effects of Varying Fat:Carbohydrate Diet Permutations on Gastric Emptying and Metabolic Status Using Human Postprandial Model

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05977244
• Other study ID #: PD233/18
• Status: Recruiting
• Phase: N/A
• Start date: May 21, 2022
• Est. completion date: March 2024

Study information

• Verified date: July 2023
• Source: Malaysia Palm Oil Board
• Contact: Gowri Ms Nagapan, MSc
• Phone: 0126673592
• Email: gowri[@]mpob.gov.my
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this clinical trial is to investigate the effects of the meals moderated by fat and carbohydrate (CHO) quality along with varying macronutrient distribution (CHO: fat) on gut physiology and metabolic outcomes using the human postprandial model with healthy subjects. The main question[s] it aims to answer are: 1. How does meal composition with different polyunsaturated/saturated (P/S) ratio, glycemic index and macronutrient quantity affect lipemia and glycemia? 2. How does meal composition with different P/S ratio, Glycemic index and macronutrient quantity affect gastric emptying?

Description:

The study's objectives will be tested via a randomized, crossover study with 16 diet rotations separated by minimum one week washout period. All recruited subjects will be randomly assigned into 2 groups of 7 each namely HGI and LGI with 9 diet rotations within each group. The study design will be a cross-over trial with the same subjects undergoing all arms of the diet rotations. The subjects will be blinded to the test fats used for each rotation. Body weight measurements will be recorded before each postprandial challenge to minimise weight fluctuations between the test rotations. Study procedures 1. Oral glucose tolerance test (OGTT) Sessions Prior and end of the test meal rotations, subjects will undergo oral glucose tolerance test (OGTT) with a glucose reference drink at 2 random sessions without MRI investigation at Taylor's University or Hospital Cancelor Tuanku Muhriz (HCTM), to get an average value for the plasma glucose and insulin standards for each subject. The glucose reference drink composition will be 50g of anhydrous glucose mixed with 250mL of room temperature water. Blood samples will be collected sequentially at 0, 15, 30, 60, 90,120 and 180 minutes. 2. Test meal sessions During each postprandial test meal rotations, subjects will consume test meals followed by MRI scans at the MRI center at Hospital Cancelor Tuanku Muhriz(HCTM). For scheduled session, Subjects will be advised to refrain from strenuous physical activity, high calorie or fast-food, supplements and coffee intake for 24 hours preceding each postprandial event. Subjects will be at the clinical center at 7:30 and 8:30a.m, following a 12-hour overnight fast. Upon arrival at the centre,subjects will rest for 10min, followed by body weight, blood pressure and self-monitoring of blood glucose (SBMG) measurements. Subsequently, blood samples will be drawn for metabolic investigations as per study objectives. Sequential postprandial MRI scans before and after test meal intake at 0(fasting), 15, 30, 60, 90, 120, 180, 240 and 300 minutes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 14
• Est. completion date: March 2024
• Est. primary completion date: March 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 40 Years

Eligibility

Inclusion Criteria:

Healthy subjects, (n=12-14) without history of chronic disease(s) with body mass index (BMI) between 18.5-25.0 kg/m2 and normal fasting blood glucose status [<5.4 mmol/L] will be enrolled into the study.

Exclusion Criteria:

1. Using pharmacotherapy that interferes with lipid and glucose metabolism or gastrointestinal transit (constipating drugs) or on oral contraceptives (women).

2. Underweight body mass index (BMI): < 18.5 kg/m2

3. With medical history of cardiovascular disease (CVD), Diabetes Mellitus, dyslipidemia and other chronic diseases,

4. acute or chronic gastrointestinal illness

5. If vulnerable to claustrophobia or anxiety

6. Regular alcohol usage

7. On low-calorie diets

8. Smoking

Related Conditions & MeSH terms

• Gastric Emptying
• Hyperlipidemias
• Postprandial Glycemia
• Postprandial Lipemia

Intervention

Other:
• HGI+palm olein
A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.
• LGI+palm olein
A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.
• HGI+soy bean oil
A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.
• LGI+soy bean oil
A 5-hour postprandial feeding intervention with 1-weeks washout in between. Blood samples will be collected at 0 hour (baseline) and up to 5 hours after consumption of test meal.

Locations

Country	Name	City	State
Malaysia	Malaysian Palm Oil Board	Kajang	Selangor

Sponsors (3)

Lead Sponsor	Collaborator
Malaysia Palm Oil Board	National University of Malaysia, Taylor's University

Country where clinical trial is conducted

Malaysia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lipemia	To determine the postprandial changes in triacylglyceride (TAG)	0, 15, 30, 60, 90, 120, 180, 240, 300minutes after ingestion of test meals
Primary	Glycemia	To determine the postprandial changes of glucose	0, 15, 30, 60, 90, 120, 180, 240, 300minutes after ingestion of test meals
Secondary	Gastric emptying	To determine the postprandial changes in half emptying time	0, 15, 30, 60, 90, 120, 180, 240, 300minutes after ingestion of test meals
Secondary	Gut hormone	To determine the postprandial changes of glucose-dependent insulinotropic polypeptide (GIP)	0, 15, 30, 60, 90, 120, 180, 240, 300minutes after ingestion of test meals